Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ciba Vision Corp.

Division of Novartis AG
www.cibavision.com

Latest From Ciba Vision Corp.

Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models

Healthy market growth, the biggest ever M&A deal, a record number of billion-dollar takeovers, and the IPO market in impressive bounce-back…2014 was a year of superlatives for the global medtech industry. But with more expected of manufacturers while health care spending remains in the doldrums and demand for care rises, the long-term medtech winners will be those who can forecast how and where to make an impact on both costs and patient outcomes.

Medical Device Deals

CooperVision Targets High-Growth Daily Lens Market With Sauflon Buy

The $1.2 billion acquisition of Sauflon Pharmaceuticals will increase Cooper’s penetration in the high-growth daily disposable silicone hydrogel contact lens market.

Medical Device

Can Isis Remain A Platform Company?

With a bulging pipeline, piles of cash, and Big Pharma partners knocking on its doors, Isis believes it is under no pressure to sell its own products. But several factors – including outside pressures and issues intrinsic to Isis’ platform model – are coming into play that may hasten its evolution into an integrated biopharma. And for the first time, Isis management appears open to the possibility.

BioPharmaceutical Deals

Asia On The Move – Personnel News From Key Players In The Region

The start of 2013 has seen a flurry of high-level personnel moves. The shake-ups in AstraZeneca will see exits of its R&D president and EVP for commercial, and Astellas will reorganize global management.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Michael Kehoe, CEO
    John McKenna, CFO
    Manohar Raheja, PhD, Global Head, R&D & Eng.
  • Contact Info
  • Ciba Vision Corp.
    Phone: (678) 415-3937
    11460 Johns Creek Pkwy.
    P.O. Box 105069 Duluth, GA 30097
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register